Incidence of cutaneous malignancy following the concomitant use of cyclosporine and narrowband UV-B phototherapy in patients with vitiligo
Clinical and Experimental Dermatology
💡
For patients with vitiligo, combining cyclosporine with narrowband UV‑B may be oncologically safe according to this nationwide cohort.
Clinical insight